Recently acquired hepatitis C infection: insights from virological, therapeutic and epidemiological studies

澳大利亚每年约有10,000例丙型肝炎（HCV）感染新病例，其中大多数未被诊断。造成这种情况的原因包括公众对现阶段治疗的好处缺乏认识。随着新的抗病毒药物的出现，对近期丙型肝炎病毒的治疗可能会变得更加容易和成功。本研究的目的是探讨丙型肝炎病毒的传播模式、治疗策略和近期丙型肝炎病毒感染者的长期健康结果。

Every year around 10,000 new cases of hepatitis C (HCV) infection occur within Australia, most of which are undiagnosed. Reasons for this include a lack of public awareness about the benefits of treatment at this stage. As new antiviral agents become available it is likely that therapy for recent HCV will become even easier and more successful. The aim of this research is to explore HCV transmission patterns, treatment strategies and long term health outcomes in people with recent HCV.